MedTrace Logo

Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease

NCT00808262 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2011-06-08

No results posted yet for this study

Summary

Evaluation of the safety and the immune response induced by active immunization through a TNFa kinoid in patients with Crohn's disease.

Conditions

Interventions

BIOLOGICAL

TNFa Kinoid

TNFa kinoid at days 0, 7, 28

Sponsors & Collaborators

  • Neovacs

    lead INDUSTRY

Principal Investigators

  • Pierre Vandepapeliere, MD, PhD · Neovacs

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • South Africa
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00808262 on ClinicalTrials.gov